218.90
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For - FinancialContent
West Pharmaceutical Names Robert McMahon as New CFO - AInvest
What analysts say about West Pharmaceutical Services Inc. stockUnprecedented profit potential - jammulinksnews.com
WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up? - TradingView
Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks - Insider Monkey
West Pharmaceutical Services Inc. Stock Analysis and ForecastDynamic portfolio growth - jammulinksnews.com
West Pharmaceutical Services taps Robert McMahon as CFO - MSN
Is West Pharmaceutical Services Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional
What drives West Pharmaceutical Services Inc. stock priceHigh-octane investment gains - Autocar Professional
West Pharmaceutical Appoints New CFO Robert McMahon - TipRanks
West pharmaceutical services appoints Robert McMahon as new CFO - Investing.com
Healthcare Veteran Robert McMahon Exits Agilent to Lead West Pharma's Financial Future - Stock Titan
West Welcomes Robert McMahon as Incoming Chief Financial Officer - The Malaysian Reserve
Mutual of America Capital Management LLC Sells 252 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Services Inc (WST) Stock Down 4.76% on July 18th - AInvest
West Pharmaceutical Services to Announce Q2 2025 Results and Host Live Conference Call - MSN
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MSN
Bank of America Securities Keeps Their Buy Rating on West Pharmaceutical Services (WST) - The Globe and Mail
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - TradingView
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory - MSN
Can West Pharmaceutical Services Inc. stock recover from recent declineChart Based Entries - Newser
Allworth Financial LP Has $96,000 Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
How West Pharmaceutical Services Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
West Pharmaceutical Services (WST) to Release Quarterly Earnings on Thursday - Defense World
Strategy To YieldBoost West Pharmaceutical Services From 0.4% To 13.2% Using Options - Nasdaq
Why West Pharmaceutical Services Inc. stock attracts strong analyst attentionFree Stock Index Interpretation - Newser
What makes West Pharmaceutical Services Inc. stock price move sharplyHigh Confidence Trade Setups - Newser
Drug Development Inputs & Services Stocks Q1 Results: Benchmarking West Pharmaceutical Services (NYSE:WST) - Yahoo Finance
Is West Pharmaceutical Services (WST) a Great Business Unfairly Sold Off by the Market? - Insider Monkey
Here's Why West Pharmaceutical Services (NYSE:WST) Can Manage Its Debt Responsibly - simplywall.st
Cambridge Investment Research Advisors Inc. Sells 281 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
Sustainable Pharmaceutical Packaging Market to Reach USD 299.95 billion by 2032 - newstrail.com
Allspring Global Investments Holdings LLC Sells 251 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
WEST ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
West Pharmaceutical Services’ Q2 2025 Earnings: What to Expect - MSN
West to Host Second-Quarter 2025 Conference Call - The Malaysian Reserve
DAVENPORT & Co LLC Has $499,000 Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):